Heparin-Induced Thrombocytopenia Case

Heparin-Induced Thrombocytopenia Case

Current Status
Not Enrolled
Get Started

Author: Dr. Stefan Jevtic (McMaster University) and Dr. Danyal Ladha (University of Toronto)

Reviewer: Dr. Natasha Rupani, University of Toronto

Learning Objectives

At the end of the self-assessment module, learners will be able to:
1) Describe an approach to the diagnosis of heparin-induced thrombocytopenia
2) Identify risk factors and clinical features associated with heparin-induced thrombocytopenia
3) Describe the management of heparin-induced thrombocytopenia, including duration and type of anticoagulation

Scientific Planning Committee

Dr. Pallavi Ganguli – Resident Physician, Hematology
Dr. Danyal Ladha – Resident Physician, Hematology
Dr. Joanne Britto – Clinical Fellow, Malignant Hematology (Lymphoproliferative Disorders)
Dr. Yan Xu – Fellow Physician, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician,
Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre

Conflict of Interest: None